FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13914311000001106: Ebixa 20mg tablets (Lundbeck Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50139101000001113 Ebixa 20mg tablets (Lundbeck Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
50139201000001118 Ebixa 20mg tablets (Lundbeck Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ebixa 20mg tablets (Lundbeck Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Is a Memantine 20mg tablets true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Has active ingredient Memantine true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Has active ingredient Memantine hydrochloride false Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Is a Ebixa true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Has specific active ingredient Memantine hydrochloride true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ebixa 20mg tablets (Lundbeck Ltd) 7 tablet Is pack of False Ebixa 20mg tablets (Lundbeck Ltd) Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) 28 tablet 2 x 14 tablets Is pack of False Ebixa 20mg tablets (Lundbeck Ltd) Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) 28 tablet 2 x 14 tablets Has AMP True Ebixa 20mg tablets (Lundbeck Ltd) Inferred relationship Existential restriction modifier
Ebixa 20mg tablets (Lundbeck Ltd) 7 tablet Has AMP True Ebixa 20mg tablets (Lundbeck Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start